![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, April 21, 2010 7:55:09 AM
Thanks for the update,... this whole last part has lots of interesting comments:
I feel that we're at an important juncture in the life of NanoViricides. We now have a number of "lead drug candidates" for an FDA filing(s) and will decide in the next 2-3 months what the submission order will be. The priority voucher program is an important consideration, especially since there are a number of tropical medicine diseases that don't require human trials except for Phase I safety when the drug is given to healthy volunteers. And, there's an immediate financial payoff once approval is obtained. Only a few non human primates are needed for the other Phases which makes the trials go rather quickly.
There is now widespread understanding in the scientific community about the usefulness of nanomedicine and particularly of our nanoparticles, called nanomicelles. You only have to go to http://nano.cancer.gov to see that they're doing the same thing in oncology, targeting and destroying individual cancer cells, as we're doing with viruses.
It's important to look into the future but at the same time make the correct decisions that will help us achieve our long-term goals
I'm most interested in seeing this S3 shelf registration go effective so we can leave this quiet period and update everyone on our most recent studies.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM